| Biodegradable PLGA microparticles for sustained release of a new GnRH antagonist: part II. In vivo performance | European journal of pharmaceutics and biopharmaceutics |  | | 2004 | 559 | 0 |
|
| Chronic inhibition of circulating dipeptidyl peptidase IV by FE 999011 delays the occurrence of diabetes in male zucker diabetic fatty rats | Diabetes |  | | 2002 | 608 | 561 |
|
| Pharmacological profile of a new, potent, and long-acting gonadotropin-releasing hormone antagonist: degarelix | The Journal of pharmacology and experimental therapeutics | | | 2002 | 603 | 917 |
|
| Chronic administration of neuropeptide Y into the lateral ventricle of C57BL/6J male mice produces an obesity syndrome including hyperphagia, hyperleptinemia, insulin resistance, and hypogonadism | Molecular and cellular endocrinology | | | 2001 | 577 | 0 |
|
| GnRH antagonists: a new generation of long acting analogues incorporating p-ureido-phenylalanines at positions 5 and 6 | Journal of medicinal chemistry | | | 2001 | 696 | 0 |
|
| Stimulation of the gonadotropic axis by the neuropeptide Y receptor Y1 antagonist/Y4 agonist 1229U91 in the male rat | Neuroendocrinology | | | 2000 | 559 | 0 |
|
| Chronic blockade of the melanocortin 4 receptor subtype leads to obesity independently of neuropeptide Y action, with no adverse effects on the gonadotropic and somatotropic axes | Endocrinology | | | 2000 | 594 | 0 |
|
| Leptin and human reproduction | Endocrine basis of reproductive function | | | 2000 | 484 | 0 |
|
| Evidence that the inhibition of luteinizing hormone secretion exerted by central administration of neuropeptide Y (NPY) in the rat is predominantly mediated by the NPY-Y5 receptor subtype | Endocrinology | | | 1999 | 564 | 0 |
|
